The Oct. 14 subpoena was related to the sales, marketing and reimbursement support practices of Medtronic’s neurostimulation devices. Medtronic has said that it will cooperate with the investigation.
Read the Wall Street Journal report on Medtronic’s subpoena.
Read other coverage on Medtronic:
– Medtronic Receives First FDA Clearance in Pediatric AIS Category for CD Horizon Spinal System
– Medtronic Receives FDA 510(k) Clearance for Spinal Cord Stimulator Trialing Cable
– Medtronic Partners With Ziehm Imaging in 3D Intraoperative Technology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
